ArticleBMC infectious diseases2025
Analysis of clinical characteristics of 213 clinically diagnosed pediatric patients with paragonimiasis from Yunnan, China.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Imported Pediatric Paragonimiasis in China: Two Cases From Zhaotong to Hangzhou.The American journal of case reports · 2026Article
- A Case of Heavy Paragonimiasis Involving a Multi-Organ Presentation with Hypereosinophilia and Hepatic Migration.The American journal of tropical medicine and hygiene · 2026Article
- Atypical subcutaneous nodule-type paragonimiasis in 3 children: case series.Frontiers in surgery · 2026Article
- Clinical Characteristics of Pediatric Pleuropulmonary Paragonimiasis with Pleural Effusion: A Single-Center Retrospective Analysis.The American journal of tropical medicine and hygiene · 2025Article
- Case Report: SimultaneousFrontiers in pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to analyze the clinical characteristics of clinically diagnosed paragonimiasis in children in Yunnan Province to enhance awareness, reduce misdiagnosis and missed diagnoses, and provide guidance for the clinical management of the disease.
methodsClinical data from 213 pediatric patients clinically diagnosed with paragonimiasis between 2014 and April 2024 were collected and retrospectively analyzed, focusing on clinical symptoms, laboratory findings, imaging changes, and treatment approaches.
resultsAmong the 213 cases, the majority were male (157 cases, 73.7%), with Han ethnicity being the most prevalent (161 cases, 75.6%), and the average age was 7.2 years. The majority of cases originated from Zhaotong City, Yunnan Province (159/213, 74.6%), particularly from Zhenxiong County (90/159, 56.6%), Yiliang County (31/159, 19.5%), and Daguan County (24/159, 15.1%). A clear epidemiological exposure history was present in 177 cases (83.1%), including the consumption of raw water, crayfish, and stream crabs. The most common clinical subtypes were complex (115 cases, 54.0%) and thoracic-pulmonary (83 cases, 39.0%). The three most prevalent clinical manifestations included cough (98 cases, 48.0%), fever (75 cases, 35.2%), and abdominal pain (63 cases, 29.6%). Elevated eosinophil levels were noted in 195 cases (91.5%). Compared to the thoracic-pulmonary subtype, the complex subtype exhibited higher proportions of Han ethnicity, Zhaotong origin, White cell count, hemoglobin levels, and length of hospitalization. All children received oral praziquantel treatment, averaging 2.6 treatment courses, with 121 cases (56.8%) also receiving glucocorticoid therapy, and 45 cases (21.1%) undergoing surgical intervention. Except for five thoracic-pulmonary subtype patients who sought surgery at external facilities, all other patients were discharged after clinical improvement. Follow-up indicated that 143 cases (67.1%) attended regular check-ups, with no residual complications.
conclusionThe clinical manifestations of clinically diagnosed paragonimiasis are diverse. In addition to immunological examinations and elevated eosinophil counts, an epidemiological history (including residence in endemic areas and consumption of raw water or crayfish) is crucial for diagnosis. After treatment primarily with praziquantel, the prognosis for the majority of patients is favorable. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.